Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

This study will evaluate the efficacy and safety of Iparomlimab and Tuvonralimab Injection in combination with Chemotherapy and Sequential Thoracic Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer.

Participants needed: 46
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The Second Affiliated Hospital of Dalian Medical UniversityUpdated: Jan 16, 2026
Eligibility criteria

For voluntary signing of the informed consent form, participants aged 18 to 75 y... [+10]

Patients with allergies or intolerance to the EP chemoradiotherapy regimen or an... [+18]

Read more
Status: Not yet recruiting

Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study

This study will evaluate the efficacy and safety of irinotecan liposome(II) in combination with Ivonescimab as second line treatment for SCLC.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The Second Affiliated Hospital of Dalian Medical UniversityUpdated: Feb 11, 2025Locations: 2
Eligibility criteria

Age ≥18 years; [+9]

Known allergy to irinotecan hydrochloride liposome injection (II) and eboxizumab... [+10]

Read more